Wedmont Private Capital’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$136K Buy
+10,055
New +$120K ﹤0.01% 936
2026
Q1
Sell
-27,889
Closed -$228K 869
2025
Q4
$228K Sell
27,889
-88,169
-76% -$697K 0.01% 738
2025
Q3
$1.23M Sell
116,058
-36,060
-24% -$354K 0.05% 231
2025
Q2
$1.51M Buy
152,118
+106,561
+234% +$1.1M 0.06% 194
2025
Q1
$509K Sell
45,557
-54,982
-55% -$846K 0.03% 379
2024
Q4
$1.59M Buy
100,539
+82,372
+453% +$1.34M 0.08% 140
2024
Q3
$329K Sell
18,167
-1,215
-6% -$25.2K 0.02% 491
2024
Q2
$413K Buy
19,382
+7,754
+67% +$154K 0.03% 398
2024
Q1
$214K Buy
+11,628
New +$200K 0.02% 552

Other funds holding OGN

Wedmont Private Capital's OGN Position: Q2 2026 in Review

Wedmont Private Capital opened a new position in Organon & Co (OGN) in Q2 2026: 10,055 shares worth $136K. The stake represents ﹤0.01% of the portfolio and ranks #936 among its holdings. This is a return to the name: Wedmont Private Capital previously reported a position in OGN as recently as Q4 2025.

Wedmont Private Capital first reported a position in OGN in Q1 2024 and has held it in 9 quarters since. The position peaked at $1.59M in Q4 2024. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Wedmont Private Capital held 10,055 shares of Organon & Co worth $136K as of Q2 2026.
  • Organon & Co was a new Wedmont Private Capital position in Q2 2026.
  • Organon & Co made up ﹤0.01% of Wedmont Private Capital's portfolio in Q2 2026, its #936 holding.
  • Wedmont Private Capital first reported a position in Organon & Co in Q1 2024 and has held it in 9 quarters since.
  • Wedmont Private Capital's Organon & Co position peaked at $1.59M in Q4 2024.
  • 631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Wedmont Private Capital's 13F filing for Q2 2026, filed 13 Jul 2026.